RE:RE:RE:RE:RE:RE:RE:RE:RE:Latest update from company
Yes, it's been a rare cordial and respectful board which makes it that much more interesting.
Thanks EMTguy for frontline perspective always! Sometimes we can just think dollar sign and lose sight of the broader picture/value and it is certainly good to get actual inputs from people in the know on this. I would be very curious to hear from someone who will be a professional with no ties to the company once this gets (hopefully) approved and put into use.
Good inputs re. going on exchanges south of the border. Maybe it's my eternal positive side, but company already has various agreements with China, Korea and other countries, some of which are joint ventures and may actually help finance some of the production costs ...and some other countries according to the latest investor propaganda document on their website. MFR (CAnon) is reputable and highly scalable - feeling good on production. It's also getting lots of attention on the pink sheets as there is more volume there than on the Canadian exchange so big boys must already have this one in sight. I don't know the specifics of the stock you are mentionning, but if and when CSS gets FDA approval, sales should be pretty explosive I think, especially with some of the agreements already in place ...they've had time to prepare and there are also many influential people in the know on board - no amateurs there ...which can be a good thing, as it can also be a bad thing if they're only there with bad intentions. Colonel Hack was also involved in setting new review methods with the FDA - which leads me to believe he was taken on the board in part because of this as it's always who you know more than what you know when trying to get approval from an agency as the FDA.
As far as I am concerned, splits don't change much on valuation of a stock inasmuch as make it more respected (vs penny stock) or accessible (when splitting to bring cost/share down when it reaches in the hundreds/share), which can lead to short term pops if perceived in a positive way ...otherwise it doesn't change anything to the actual inherent value of the company. If it does get approved, sales have the potential of being exponential over the first 3-5 years - which would take care of the shorts. Personally, I'm not really in this thing to try to make a quick buck or play the swings inasmuch as for long haul of a few years and see where it does indeed go and if it does get bought out at some point as most like it end up. Again, that the stock goes from 0.35 to 0.20 or back right now, I think is somewhat petty in the long run. And it's always buy the rumor, sell the news, so those who will be trying to make a quick buck along the way can always try to play the swings, and there's been a few occasions already, but I'm thinking on a longer term personally.
In a sepate order of idea, what would be the main things you think one could look for as suspicious moves from management other than issuing excessive shares/warrants/options at bad valuations with further dilution using sales/marketing/production as a reason? Maybe this is what already took place to drive the share price down to issue the recent ones at lower valuations as one could imagine... Again, on this I do like some of the agreements they have with China and others as joint ventures so they don't have to finance everything themselves upfront, and one can certainly expect such moves coming from a startup.
Anywho, always open/interested in bouncing ideas, especially when it's done in a respectful/cordial manner as has been done here by most.